Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Inv. presentation
Credit agrmnt [a]
Director departure
CC transcript
NOVANTA INC (NOVT)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/08/2023
8-K
Quarterly results
Docs:
"
Novanta Announces Financial Results for the Second Quarter 2023 • Second Quarter 2023 GAAP Revenue increased 7% to $229 million • Second Quarter 2023 GAAP Net Income of $21 million • Second Quarter 2023 GAAP Diluted Earnings Per Share of $0.58 • Second Quarter 2023 Adjusted Earnings Per Share of $0.80 • Second Quarter 2023 Adjusted EBITDA of $52 million BEDFORD, Mass., August 8, 2023 -- Novanta Inc. , a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the second quarter 2023. Financial Highlights Three Months Ended June 30, July 1, 2023 2022 GAAP Revenue $ 229.5 $ 215.4 Operating Income $ 32.2 $ 23.3 Consolidated Net Income $ 20.9 $ 17.5 Diluted EPS $ 0.58 $ 0.49 Non-GAAP* Adjusted...
"
05/11/2023
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
05/09/2023
8-K
Quarterly results
Docs:
"
Novanta Announces Financial Results for the First Quarter 2023 • First Quarter 2023 GAAP Revenue increased 7% to $219 million • First Quarter 2023 GAAP Net Income of $18 million • First Quarter 2023 GAAP Diluted Earnings Per Share of $0.51 • First Quarter 2023 Adjusted Earnings Per Share of $0.74 • First Quarter 2023 Adjusted EBITDA of $47 million BEDFORD, Mass., May 9, 2023 -- Novanta Inc. , a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2023. Financial Highlights Three Months Ended March 31, April 1, 2023 2022 GAAP Revenue $ 219.1 $ 204.2 Operating Income $ 26.3 $ 24.3 Consolidated Net Income $ 18.3 $ 18.8 Diluted EPS $ 0.51 $ 0.53 Non-GAAP* Adjusted Operati...
"
03/10/2023
8-K
Regulation FD Disclosure Interactive Data
03/01/2023
8-K
Quarterly results
11/08/2022
8-K
Quarterly results
Docs:
"
Three Months Ended September 30, October 1, 2022 2021 GAAP Revenue $ 223.0 $ 177.7 Operating Income $ 28.7 $ 15.3 Consolidated Net Income $ 22.5 $ 13.6 Diluted EPS $ 0.63 $ 0.38 Non-GAAP* Adjusted Operating Income $ 40.0 $ 31.6 Adjusted Diluted EPS $ 0.81 $ 0.75 Adjusted EBITDA $ 49.4 $ 40.4 *Reconciliations of GAAP to non-GAAP financial measures, as well as definitions for the non-GAAP financial measures included in this press release and the reasons for their use, are presented below. “Novanta delivered another record quarter,” said Matthijs Glastra, Chair and Chief Executive Officer of Novanta. “In the third quarter, we delivered double-digit growth for sales and Adjusted EBITDA. Our teams were able to deliver excellent financial performance despite inflationary pre...
"
08/09/2022
8-K
Quarterly results
07/26/2022
8-K
Quarterly results
07/11/2022
8-K
Quarterly results
06/28/2022
8-K
Quarterly results
05/16/2022
8-K
Quarterly results
05/10/2022
8-K
Quarterly results
03/15/2022
8-K
Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
"
Fifth Amendment to Third Amended and Restated Credit Agreement. (Pursuant to Item 601 (a)(5) of Regulation S-K, certain schedules and exhibits have been omitted. The registrant hereby agrees to furnish supplementally a copy of any omitted schedule and exhibit to the Securities and Exchange Commission upon request.)
"
03/01/2022
8-K
Quarterly results
11/12/2021
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/09/2021
8-K
Quarterly results
Docs:
"
Novanta Announces Financial Results for the Third Quarter 2021
"
10/07/2021
8-K
Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
"
Fourth Amendment to Third Amended and Restated Credit Agreement
"
08/31/2021
8-K
Quarterly results
08/10/2021
8-K
Quarterly results
Docs:
"
Novanta Announces Financial Results for the Second Quarter 2021
"
07/19/2021
8-K
Quarterly results
07/12/2021
8-K
Entry into a Material Definitive Agreement Interactive Data
05/14/2021
8-K
Quarterly results
05/11/2021
8-K
Quarterly results
04/16/2021
8-K
Quarterly results
03/23/2021
8-K
Quarterly results
03/01/2021
8-K
Quarterly results
12/11/2020
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/10/2020
8-K
Quarterly results
Docs:
"
Third Quarter 2020 GAAP Revenue of $143 million • Third Quarter 2020 GAAP Net Income of $8 million • Third Quarter 2020 GAAP Diluted Earnings Per Share of $0.23 • Third Quarter 2020 Adjusted Earnings Per Share of $0.42 • Third Quarter 2020 Adjusted EBITDA of $30 million
"
08/06/2020
8-K
Quarterly results
06/22/2020
8-K
Quarterly results
05/27/2020
8-K
Submission of Matters to a Vote of Security Holders Interactive Data
05/12/2020
8-K
Quarterly results
Docs:
"
First Quarter 2020 GAAP Revenue of $155.5 million • First Quarter 2020 GAAP Net Income of $11.9 million • First Quarter 2020 GAAP Diluted Earnings Per Share of $0.34 • First Quarter 2020 Adjusted Earnings Per Share of $0.51 • First Quarter 2020 Adjusted EBITDA of $27.6 million
"
05/11/2020
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs:
"
Letter Agreement, between Novanta Inc. and Matthijs Glastra
",
"
Letter Agreement, between Novanta Inc. and Robert J. Buckley
",
"
Letter Agreement, between Novanta Inc. and Brian S. Young
"
04/08/2020
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ...
Docs:
"
Amendment Number 3 to By-Law Number 1
"
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy